CAR-Based Cell and Gene Therapies: Global Clinical Landscape and Emerging Therapeutic Strategies from ClinicalTrials.gov.

Interestingly, when examined over time, a clear trend emerges: since 2014, there has been a sharp rise in industry-sponsored CAR-T research and development efforts, while CAR-NK therapies, which began emerging after 2016, have consistently involved industry sponsorship ( Fig. 3B , 3C ).

also in 19,460 other papers